← All Scisparc LTD filings

Scisparc LTD 20-F annual reports

The annual report filed by foreign private issuers listed on a US exchange — the 10-K’s equivalent for non-US companies.

NASDAQ
SPRC
Scisparc LTD
20-F: NeuroThera Labs Acquires CliniQuantum Ltd. in Share Deal
NeuroThera Labs Inc. has entered into a definitive agreement to acquire a majority stake in CliniQuantum Ltd., a quantum computing bio data analytics company, in a share-based transaction.
NASDAQ
SPRC
Scisparc LTD
20-F: SciSparc Ltd. Files 20-F Annual Report, Details Cannabinoid Therapy Development and AutoMax Merger
SciSparc Ltd. files its 20-F annual report, highlighting its focus on cannabinoid therapies, clinical development programs, and the proposed merger with AutoMax Motors Ltd.
NASDAQ
SPRC
Scisparc LTD
20-F/A: SciSparc Files Amended 20-F Report Including Updated Auditor's Report
SciSparc Ltd. files an amendment to its annual report on Form 20-F to include an updated report from its independent registered public accounting firm.
NASDAQ
SPRC
Scisparc LTD
20-F: SciSparc Ltd. Reports Financial Results for Fiscal Year 2023, Outlines Key Developments
SciSparc Ltd. reports a net loss of $5.9 million for 2023, alongside progress in cannabinoid therapy development and e-commerce operations.